Cefdinir Dosing and Duration for Pediatric Acute Otitis Media
For children with acute otitis media, cefdinir should be dosed at 14 mg/kg/day (either 7 mg/kg every 12 hours OR 14 mg/kg once daily) for 10 days in children under 2 years, and either 5-10 days for children 2-5 years old, with 10 days preferred for severe cases. 1
Dosing Regimen
The FDA-approved dosing for cefdinir in pediatric AOM is straightforward 1:
- Total daily dose: 14 mg/kg/day (maximum 600 mg/day)
- Frequency options:
- 7 mg/kg every 12 hours, OR
- 14 mg/kg once daily
Both once-daily and twice-daily dosing have been shown to be equally effective for AOM 1. The once-daily option may improve adherence, which is particularly valuable in outpatient pediatric practice.
Duration of Treatment
Duration should be stratified by age 2:
- Children < 2 years: 10 days (standard duration)
- Children 2-5 years: 7 days is acceptable for mild-to-moderate AOM; 10 days for severe cases
- Children ≥ 6 years: 5-10 days for mild-to-moderate AOM 1
The 2013 AAP guidelines emphasize that younger children and those with severe symptoms benefit from the full 10-day course 2.
Critical Caveats About Cefdinir Efficacy
Important limitation: While cefdinir is FDA-approved for AOM, recent comparative effectiveness data reveals significant concerns. A large 2012 head-to-head trial found that 10 days of high-dose amoxicillin-clavulanate achieved 86.5% clinical cure versus only 71.0% with 5 days of cefdinir (p=0.001) 3. More concerning, cefdinir's effectiveness decreased as children aged from 6-24 months, suggesting weight-based dosing may be inadequate 3.
Additionally, pharmacokinetic studies demonstrate that even at 25 mg/kg/day (higher than the approved 14 mg/kg/day), cefdinir achieves bactericidal levels for <40% of the dosing interval against penicillin-nonsusceptible S. pneumoniae 4. Eradication rates for penicillin-resistant S. pneumoniae were only 43% with high-dose cefdinir 5.
Clinical Context and Positioning
Cefdinir should NOT be first-line therapy for AOM. Current guidelines position cefdinir as an alternative when 2:
- Amoxicillin or amoxicillin-clavulanate has failed
- True penicillin allergy exists (though NOT for type 1 hypersensitivity reactions)
- Coverage for H. influenzae and M. catarrhalis is needed after amoxicillin failure
A 2022 nationwide cohort study of over 1 million children confirmed that amoxicillin had the lowest combined failure and recurrence rate (1.7%) compared to cefdinir (10.0%) 6. This supports amoxicillin as the continued first-line agent.
Practical Prescribing Details
For weight-based dosing calculations 1:
- 18 kg child: 5 mL of 250 mg/5 mL suspension every 12 hours OR 10 mL once daily
- 27 kg child: 7.5 mL every 12 hours OR 15 mL once daily
- ≥43 kg: Maximum dose of 600 mg/day (12 mL of 250 mg/5 mL twice daily OR 24 mL once daily)
The suspension can be given without regard to meals 1, though high-fat meals reduce absorption by 33-44% 1. For practical purposes, this reduction is not clinically significant based on efficacy studies conducted without meal restrictions.
Renal Dosing Adjustment
For children with creatinine clearance <30 mL/min/1.73 m²: reduce to 7 mg/kg once daily (maximum 300 mg) 1.
Key Pitfall to Avoid
Do not use cefdinir as empiric first-line therapy for AOM. Despite its convenience as once-daily dosing, the evidence clearly demonstrates inferior outcomes compared to amoxicillin or high-dose amoxicillin-clavulanate 3, 6. Reserve cefdinir for specific scenarios where penicillins have failed or cannot be used, and recognize that treatment failure rates will be higher, particularly in younger children and those with resistant pathogens.